Hepatitis Markers:医療検査市場2014

◆英語タイトル:Hepatitis Markers Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

◆発行会社(調査会社):Venture Planning Group
Local LicenseUSD9,500 ⇒換算¥1,054,500見積依頼/購入/質問フォーム
Global LicenseUSD20,900 ⇒換算¥2,319,900見積依頼/購入/質問フォーム
DataPackUSD6,250 ⇒換算¥693,750見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規販売代理店です。Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

     - Hospitals
     - Commercial/Private Labs
     - Blood Banks
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 320 pages and 93 tables




★調査レポート[Hepatitis Markers:医療検査市場2014]販売に関する免責事項
★調査レポート[Hepatitis Markers:医療検査市場2014]についてメールでお問い合わせ